Zacks Investment Research cut shares of VWR Corporation (NASDAQ:VWR) from a buy rating to a hold rating in a report released on Thursday.

According to Zacks, “VWR’s second-quarter earnings report was quite impressive, with both the top and the bottom line beating the Zacks Consensus Estimate. Geographically, the company recorded growth in Americas during the reported quarter driven by strong sales of equipment and instrumentation. Management is also looking forward to the long-term synergy benefits from the proposed merger with Avantor. The merger is expected to strengthen VWR’s business across the Americas and Europe. While we await the merger to close in the fourth quarter of 2017 we note that the stock price has already reached close to Avantor’s offer price and hence the short-term upside potential of VWR is limited now. On the flip side, a drop in EMEA-APAC sales was disappointing. Moreover, foreign currency was a major dampener. VWR’s poor margin scenario also raises concern.”

A number of other equities research analysts also recently issued reports on the stock. BidaskClub downgraded shares of VWR Corporation from a sell rating to a strong sell rating in a research report on Saturday, September 2nd. ValuEngine upgraded shares of VWR Corporation from a hold rating to a buy rating in a research report on Wednesday, September 6th. One research analyst has rated the stock with a sell rating, four have given a hold rating and two have assigned a buy rating to the company. The stock has an average rating of Hold and an average price target of $31.67.

Shares of VWR Corporation (NASDAQ VWR) opened at 33.14 on Thursday. The stock has a market capitalization of $4.37 billion, a price-to-earnings ratio of 30.69 and a beta of 1.19. The firm’s 50-day moving average price is $33.03 and its 200 day moving average price is $31.36. VWR Corporation has a 1-year low of $24.42 and a 1-year high of $37.25.

VWR Corporation (NASDAQ:VWR) last announced its quarterly earnings data on Monday, July 31st. The medical research company reported $0.49 EPS for the quarter, beating the Zacks’ consensus estimate of $0.45 by $0.04. The firm had revenue of $1.18 billion during the quarter, compared to the consensus estimate of $1.16 billion. VWR Corporation had a net margin of 3.12% and a return on equity of 15.54%. The firm’s revenue was up 2.2% compared to the same quarter last year. During the same quarter last year, the firm earned $0.42 earnings per share. Equities research analysts expect that VWR Corporation will post $1.87 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “VWR Corporation (VWR) Stock Rating Lowered by Zacks Investment Research” was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of US & international copyright laws. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/09/18/vwr-corporation-vwr-stock-rating-lowered-by-zacks-investment-research.html.

Several hedge funds have recently bought and sold shares of VWR. FNY Managed Accounts LLC acquired a new stake in shares of VWR Corporation during the 1st quarter valued at approximately $100,000. Teacher Retirement System of Texas acquired a new stake in shares of VWR Corporation during the 1st quarter valued at approximately $205,000. Neuberger Berman Group LLC acquired a new stake in shares of VWR Corporation during the 1st quarter valued at approximately $219,000. PNC Financial Services Group Inc. lifted its position in shares of VWR Corporation by 954.2% during the 1st quarter. PNC Financial Services Group Inc. now owns 8,455 shares of the medical research company’s stock valued at $238,000 after acquiring an additional 7,653 shares during the period. Finally, Capstone Asset Management Co. lifted its position in shares of VWR Corporation by 24.6% during the 1st quarter. Capstone Asset Management Co. now owns 10,670 shares of the medical research company’s stock valued at $301,000 after acquiring an additional 2,110 shares during the period.

About VWR Corporation

VWR Corporation is a provider of product and service solutions to laboratory and production customers. The Company offers a portfolio of branded and private label laboratory products, services and solutions to the life science, general research and applied markets. The Company operates in two segments: Americas and EMEA-APAC.

Get a free copy of the Zacks research report on VWR Corporation (VWR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Stock Ratings for VWR Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VWR Corporation and related stocks with our FREE daily email newsletter.